Cervicitis by Iontophoresis

Effectiveness of Iontophoresis in Managing Uterine Cervicitis

NCT05675293•October 6 University

View on ClinicalTrials.gov

Summary

The purpose of the study is to: Investigate effect of iontophoresis on managing uterine cervicitis.

Eligibility

Age

20 - 50 years

Sex

FEMALE

Healthy Volunteers

Inclusion Criteria

•1. All patients have vaginal discharge.
•2. All patients have irregular vaginal bleeding, especially after sexual intercourse.
•3. All patients have dyspareunia.
•4. All patients have Lower abdominal pain.
•5. Group A: 20 women will receive oral medication (antibiotic zesrosin) and hot water with antiseptic.
•6. Group B: 20 women will receive medication by iontophoresis (antibiotic ceftriaxone) and hot water with antiseptic.

Exclusion Criteria

•1. Patients with a history of hypersensitivity or adverse reactions associated with the delivered drug in (ceftriaxone).
•2. Patients with prior medical histories of cardiac arrhythmias or hypercoagulability should not receive the procedure near cardiac pacemakers and superficial blood vessels.
•3. In the vicinity of embedded wires, stapes, orthopedic implants, and areas of skin with lesions and impaired sensation.
•4. It either should not be used or used with extreme caution during pregnancy.

Key Dates

Start Date

January 15, 2023

Primary Completion Date

February 1, 2023

Completion Date

February 1, 2023

Last Updated

January 11, 2023

Enrollment

ESTIMATED participants

Conditions

CERVICITIS

Interventions

IONTOPHORESIS

DEVICE

ORAL ANTIBIOTIC

DRUG

Contacts

MARIAM HELMY, DEMONSTRATOR

CONTACT

01129985772 MARIAMHELMYMHR@GMAIL.COM

Empiric Therapy of Mucopurulent Cervicitis (MPC)

NCT01072136

Vaginitis BacterialCervicitis

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 11, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions